The World Health Organization has dealt a blow to Quebec-based Medicago after formally rejecting its COVID-19 vaccine for emergency use due to its ties to cigarette maker Philip Morris International.
A Montreal infectious diseases specialist is leading a new COVID-19 vaccine trial testing the Moderna vaccine on six-month-old to six-year-old children, the last and youngest group of kids to be eligible for vaccination in Canada.
Altruistic Montrealers needed for trial on Medicago s Quebec-developed COVID-19 vaccine montreal.ctvnews.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from montreal.ctvnews.ca Daily Mail and Mail on Sunday newspapers.
MONTREAL Quebec City-based pharmaceutical developer Medicago has announced it’s ready to move forward with a phase three clinical trial of its COVID-19 vaccine candidate, after seeing “positive” interim results from phase two, the company said on Tuesday. An adjuvant or ‘booster’ produced by GlaxoSmithKline and administered along with the vaccine will also be studied. Both the U.S. Food and Drug Administration and Health Canada have approved the enrollment of up to 30,000 healthy adults worldwide, some of them in Montreal. We welcome phase 3 of @medicagoinc’s trials. has secured 20M doses w/ options for an additional 56M doses of their vaccine candidate - 1 of our 7 agreements.
A Quebec company is developing its own COVID-19 vaccine and Montrealers are taking part in Phase 2 of testing montreal.ctvnews.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from montreal.ctvnews.ca Daily Mail and Mail on Sunday newspapers.